Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04112433 · ClinicalTrials.gov registry record

Novel Cardiac Signal Processing System

A clinical trial of Cardiac Arrhythmia, sponsored by BioSig Technologies.

Completed
Registry status
104
Enrollment target
3
Study locations

NCT04112433: Completed study of Cardiac Arrhythmia, sponsored by BioSig Technologies.

NCT04112433 is a study of Cardiac Arrhythmia that has completed, run by BioSig Technologies. The registered enrollment target is 104 participants, below the 205-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (49% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04112433, a study of Cardiac Arrhythmia, has completed, sponsored by BioSig Technologies.

COMPLETED
Registry status
104 participants
Enrollment target
3
Study locations

Study Summary

This study is designed to collect parallel intracardiac signal data during pre-defined periods of clinical interest from the PURE EP system and the existing signal recording and mapping systems. The collected signals will then undergo BLINDED, CONTROLLED evaluation by unbiased electrophysiologist reviewer(s) to determine whether the PURE EP signals provides additional or clearer diagnostic information.

Conditions Studied

Cardiac Arrhythmia

Interventions

  • DEVICE PURE EP 2

Study Locations (3)

Florida

  • Mayo Clinic Jacksonville - Jacksonville

Massachusetts

  • Massachusetts General Hospital - Boston

Texas

  • St. David's Medical Center - Austin

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2019-11-12
Est. Completion 2022-01-29

Sponsor

BioSig Technologies

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04112433

The ClinicalTrials.gov registry entry for NCT04112433 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (49% lower). The listed sponsor is BioSig Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which PURE EP 2 is the first listed.

NCT04112433 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, Texas.

Frequently Asked Questions

What is clinical trial NCT04112433 about?

NCT04112433 is a clinical study titled "Novel Cardiac Signal Processing System". This study is designed to collect parallel intracardiac signal data during pre-defined periods of clinical interest from the PURE EP system and the existing signal recording and mapping systems. The collected signals will then undergo BLINDED, CONTROLLED evaluation by unbiased electrophysiologist r...

What is the current status of trial NCT04112433?

This trial is currently completed. The enrollment target is 104 participants. The study started on 2019-11-12. Estimated completion is 2022-01-29.

What conditions does trial NCT04112433 study?

This clinical trial studies the following conditions: Cardiac Arrhythmia.

What interventions are being tested in trial NCT04112433?

The interventions under investigation include: PURE EP 2 (DEVICE).

Who is sponsoring clinical trial NCT04112433?

This trial is sponsored by BioSig Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04112433 being conducted?

This trial has 3 study locations across Florida, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiac Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiac Arrhythmia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.